Apcotex industries Limited has announced an inter-se transfer of shares among its promoters, as disclosed in a regulatory filing dated March 11, 2026. The transaction involves the transfer of 62,280 shares without any monetary consideration between promoter entities.

Transaction Details

The share transfer involves Rita Ashok Parekh acquiring 62,280 shares from Mrs. Rita Ashok Parekh & Mrs. Janaki Parekh, both promoters of the company. The proposed acquisition date is scheduled for March 18, 2026.

Shareholding Impact

The transaction will result in changes to the promoter shareholding pattern. Rita Ashok Parekh's stake will increase from her current holding, while the selling promoters will reduce their positions to zero.

Regulatory Compliance

The transaction is being conducted under regulation 10(1)(a)(i) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, which exempts the acquirer from making an open offer. The company has declared compliance with all applicable disclosure requirements under Chapter V of the Takeover Regulations.

Market Reference Price

The volume weighted average market price for 60 trading days preceding the notice date was ₹364.16 on NSE, where maximum trading volume was recorded. The acquirer has declared that the acquisition price will not exceed 25% above this reference price, though the current transaction involves no monetary consideration.

Corporate Governance

The disclosure demonstrates the company's commitment to transparency and regulatory compliance. All required declarations regarding compliance with SEBI takeover regulations have been made by the acquirer, ensuring adherence to corporate governance standards for inter-se transfers among promoters.

Apcotex Industries Limited has announced a significant capacity addition project worth INR 210 crores for nitrile rubber and synthetic latex production, as detailed in its February 2026 investor presentation filed with the National Stock Exchange of India and BSE Limited. The presentation was digitally signed by Drigesh Mittal, Head - Company Secretary and Legal.

Strategic Expansion Initiative

The company has initiated this substantial investment to consolidate its position in carpet, construction, textile, paper, and rubber products segments. This expansion aims to meet growing domestic and international demand while strengthening Apcotex's global presence, particularly in South East Asia, Middle East, and Africa.

Company Overview and Market Position

Apcotex Industries operates as a leading producer of synthetic rubber and synthetic latex in India, with one of the broadest ranges of emulsion polymers available in the market. The company maintains an approximate market capitalization of INR 19,382.24 Mn as of 31st December 2025.

The company has achieved recognition as part of the Top 10 Indian companies on Forbes Asia Best Under A Billion 2023 list. Apcotex serves marquee clients across multiple industries including ITC, Asian Paints, Ultratech Cement, MRF, SRF, and Paragon Footwear.

Manufacturing Capabilities and Product Portfolio

Apcotex operates two strategically located manufacturing facilities on India's western coast. The Taloja facility in Maharashtra produces 1,03,000 MTPA synthetic latex and 7,000 MTPA high styrene rubber. The Valia facility in Gujarat manufactures 21,000 MTPA nitrile rubber and allied products, along with 50,000 MTPA nitrile latex.

Product Applications:

• Synthetic Latex: Paper and paperboard manufacturing, carpet backing, textile finishing, construction materials, tyre cord dipping, medical gloves
• Synthetic Rubber: Nitrile Rubber (NBR) for automotive applications, NBR Polyblends, High Styrene Rubber for footwear, NBR Powder for brake pads

Financial Performance Overview

The presentation includes comprehensive financial data spanning multiple periods:

For FY25, the company reported operational revenue of INR 13,924 Mn, EBITDA of INR 1,247 Mn, and PAT of INR 541 Mn. The diluted earnings per share for FY25 stood at INR 10.43.

Research and Development Capabilities

Apcotex maintains strong R&D capabilities with 38 employees dedicated to research and technical support. The company operates specialized laboratories including product development labs, quality assurance facilities, and product application centers. The company has achieved multiple quality certifications including ISO 9001, ISO 14001, OHSAS 18001, and Responsible Care certification.